EMC Capital Management »

Catalyst Pharmaceutical Partners shares owned by EMC Capital Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by EMC Capital Management from 13F filings

Historical chart of EMC Capital Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by EMC Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by EMC Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $479k 29k 16.82
2023-09-30 $333k 29k 11.69
2023-06-30 $383k 29k 13.45
2023-03-31 $472k 29k 16.57
2022-12-31 $530k 29k 18.61
2022-09-30 $365k 29k 12.81
2022-06-30 $200k 29k 7.02
2022-03-31 $382k 50k 7.62

More positions owned by EMC Capital Management

Vanguard S&p 500 Etf idx (VOO)
Invesco Qqq Trust Series 1 (QQQ)
Alphabet Inc Class C cs (GOOG)
Amazon (AMZN)
iShares Russell 2000 Index (IWM)
Vanguard Growth ETF (VUG)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Sterling Construction Company (STRL)
Crowdstrike Hldgs Inc cl a (CRWD)
Modine Manufacturing (MOD)
Hf Sinclair Corp Spon Adr (DINO)
Amkor Technology (AMKR)
Servicenow (NOW)
Atkore Intl (ATKR)

View all positions for EMC Capital Management

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
LSV Asset Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners